Results 281 to 290 of about 767,890 (335)

Application potential of induced pluripotent stem cells in the research and treatment of autoimmune diseases (Review)

Z.‐Q. Ye, Hanwei Zhao, X. Ye
openalex   +2 more sources

⁠Engineering Adaptive Immunity in 3D: A Patient‐Specific Lymphoid Model Using Stromal Networks and Peripheral Blood Mononuclear Cells

Advanced Science, EarlyView.
This study presents a 3D lymphoid tissue model engineered from adipose‐derived stem cells differentiated into fibroblastic reticular cell–like networks and co‐cultured with immune cells. The engineered system successfully generates antigen‐specific antibodies and cytokine responses, providing a platform for studying adaptive immunity, vaccine efficacy,
Mei ElGindi, Shaza Karaman, Jeremy Teo
wiley   +1 more source

Shared Genetic Architecture Between Atopic Dermatitis and Autoimmune Diseases. [PDF]

Int J Mol Sci
Lazanas P, Antonatos C, Tsoumani KT, Sgourou A, Vasilopoulos Y.   +4 more
europepmc   +1 more source

Metabolic Reprogramming Driven by Trophoblasts and Decidual XCR1+PMN‐MDSC Crosstalk Controls Adverse Outcomes Associated With Advanced Maternal Age

Advanced Science, EarlyView.
The interaction between trophoblasts and decidual polymorphonuclear myeloid‐derived suppressor cells (dPMN‐MDSCs) via the XCL1–XCR1 axis is crucial for fetal development during the third trimester. Disruption of this axis impairs FOXO1 activity and causes metabolic imbalance in dPMN‐MDSCs, contributing to adverse outcomes associated with advanced ...
Meiqi Chen, Yuxiong Guo, Qing Zhao, Jingping Liu, Shuyi Kuang, Zhengcong Huang, Chenlin Lv, Shuxiu Xu, Zekai Zhuang, Anyan Yang, Jing Li, Kai Wu, Yumei He   +12 more
wiley   +1 more source

Elevated neutrophil-to-lymphocyte ratio and the incidence of autoimmune diseases: evidence from a large prospective cohort study. [PDF]

Sci Rep
Yoon D, Yun C, Beerman I, Beydoun MA, Launer LJ, Song M.   +5 more
europepmc   +1 more source

PRRs-Dependent and Independent Mechanisms of STING Signaling in Inflammatory and Autoimmune Diseases. [PDF]

Biomedicines
Xu L, Li J, Zhu X, Zhou L, Sun Z, Zhang Z, Xu W, Song Y.   +7 more
europepmc   +1 more source

Cellular and humoral vaccination response under immunotherapies-German consensus on vaccination strategies in neurological autoimmune diseases. [PDF]

Ther Adv Neurol Disord
Schraad M, Mäurer M, Salmen A, Ruck T, Uphaus T, Fleischer V, Luessi F, Protopapa M, Steffen F, Hanuscheck N, Pape K, Brummer T, Shin J, Korn T, Klotz L, Lünemann JD, Pawlitzki M, Weber MS, Bayas A, Wildemann B, Hartung HP, Then Bergh F, Warnke C, Zettl UK, Berthele A, Haghikia A, Linker R, Tumani H, Meuth SG, Hemmer B, Wiendl H, Kümpfel T, Gold R, Bittner S, Zipp F.   +34 more
europepmc   +1 more source

TRIM21 regulation of IRF-mediated type I interferon signaling in systemic autoimmune diseases. [PDF]

Front Immunol
Panlu K, Wang Y, Zhu X, Lin Z, Fang T, Yao X, Xie Z, Wang X.   +7 more
europepmc   +1 more source

Cardiovascular Risk in Autoimmune Diseases: Mechanisms, Management, and Emerging Evidence. [PDF]

Cureus
Baloch MB, Alphonse C, Baldev N, Nin-Arroyo GM, Keezhath R, Behara A, Khurana S, Nwokeji S, Imam B, Abarca-Pineda YA.   +9 more
europepmc   +1 more source

Lymphoma risk in autoimmune diseases with multiple medication use: analysis from the LIFE Study. [PDF]

Blood Cancer J
Inokuchi A, Kim H, Sakurai M, Masuda K, Mizuno K, Koda Y, Matsuki E, Kogure Y, Ukita S, Maeda M, Oda F, Kaneko Y, Sato Y, Fukuda H, Kataoka K.   +14 more
europepmc   +1 more source